Richard Edlin Net Worth & Insider Trades

Richard Edlin - Director, Eagle Pharmaceuticals, Inc

As of March 9, 2023

What is Richard Edlin's Net Worth?

The current estimated net worth of Eagle Pharmaceuticals, Inc's Director, Richard Edlin, is estimated to be about $1.03M . Richard Edlin owns about 22,600 units of Eagle Pharmaceuticals, Inc common stock. In the last 6 years at Eagle Pharmaceuticals, Inc, Richard Edlin has sold an estimated value of $210.73K worth.

What is Richard Edlin's Past Insider Trading?

Richard Edlin's largest purchase order was 6,000 units , worth over $476.64K on March 22, 2017. Richard Edlin's largest sale order was 6,800 units , worth over $210.73K on September 8, 2022. In total, Richard Edlin has made about 9 transactions over 6 years of their time at Eagle Pharmaceuticals, Inc. Richard Edlin usually trades in March, with the busiest year in 2022 and 2017.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Richard Edlin

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Richard Edlin's' Mailing Address?

  • Mailing address is C/o Eagle Pharmaceuticals, Inc. 50 Tice Boulevard, Suite 315 Woodcliff Lake NJ 07677 NJ

What are Eagle Pharmaceuticals, Inc's Past Insider Trades?

Eagle Pharmaceuticals, Inc's most recent insider trade came on May 18, 2023 by Scott Tarriff who sold 15,000 units worth $299.7K . In the last 9 years, insiders at Eagle Pharmaceuticals, Inc have sold an estimated value of $147.23M and bought an estimated value of $21.4M worth of shares. Insider trading is most common in January, with the busiest year in 2016. The most active traders at the company are Scott Tarriff, CEO,  Alain Schreiber,  and Jay Moorin .

EAGLE PHARMACEUTICALS, INC. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...